GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » EV-to-EBIT

MMSI (Merit Medical Systems) EV-to-EBIT : 32.98 (As of Jul. 12, 2025)


View and export this data going back to 1990. Start your Free Trial

What is Merit Medical Systems EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Merit Medical Systems's Enterprise Value is $6,047 Mil. Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $183 Mil. Therefore, Merit Medical Systems's EV-to-EBIT for today is 32.98.

The historical rank and industry rank for Merit Medical Systems's EV-to-EBIT or its related term are showing as below:

MMSI' s EV-to-EBIT Range Over the Past 10 Years
Min: -1151.46   Med: 47.18   Max: 464.06
Current: 32.98

During the past 13 years, the highest EV-to-EBIT of Merit Medical Systems was 464.06. The lowest was -1151.46. And the median was 47.18.

MMSI's EV-to-EBIT is ranked worse than
71.24% of 459 companies
in the Medical Devices & Instruments industry
Industry Median: 20.19 vs MMSI: 32.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Merit Medical Systems's Enterprise Value for the quarter that ended in Mar. 2025 was $6,667 Mil. Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $183 Mil. Merit Medical Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 2.75%.


Merit Medical Systems EV-to-EBIT Historical Data

The historical data trend for Merit Medical Systems's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems EV-to-EBIT Chart

Merit Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,070.68 63.73 47.85 36.83 33.66

Merit Medical Systems Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.93 31.27 34.30 33.66 36.36

Competitive Comparison of Merit Medical Systems's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's EV-to-EBIT falls into.


;
;

Merit Medical Systems EV-to-EBIT Calculation

Merit Medical Systems's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6046.631/183.344
=32.98

Merit Medical Systems's current Enterprise Value is $6,047 Mil.
Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $183 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems  (NAS:MMSI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Merit Medical Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=183.344/6667.26338
=2.75 %

Merit Medical Systems's Enterprise Value for the quarter that ended in Mar. 2025 was $6,667 Mil.
Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $183 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Executives
Fred P Lampropoulos director, officer: President & CEO
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas James Gunderson director 5905 LONG BRAKE TRAIL, EDINA MN 55439
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132